Drug Pipeline

ATRN-119 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-01 NCT07617363 ATRN-119 in Combination With Decitabine in Patients With TP53-Mutated AML or Higher-Risk… Phase 1 Not Yet Recruiting
Active Studies by Phase
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT04905914 Study Of ATRN-119 In Patients With Advanced Solid Tumors Advanced Solid Tumor Active, Not Recruiting
NCT07578467 Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+… HPV Positive Oropharyngeal Squamous Cell Carcinoma Not Yet Recruiting
Phase 1
NCT07617363 ATRN-119 in Combination With Decitabine in Patients With TP53-Mutated AML or Higher-Risk… Acute Myeloid Leukemia Not Yet Recruiting
Sponsors Running ATRN-119 Trials
Aprea Therapeutics (1) John Lukens (1) Washington University School of Medicine (1)
Disease Areas
Leukemia (1) Acute Myeloid Leukemia (AML) (1) Myelodysplastic Syndromes (MDS) (1)
Get alerts when ATRN-119 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free